How to buy Integra LifeSciences Holdings Corporation (IART) stock

Integra LifeSciences Holdings Corporation is a medical devices business based in the US. Integra LifeSciences Holdings Corporation shares (IART) are listed on the NASDAQ and all prices are listed in US Dollars. Integra LifeSciences Holdings Corporation employs 3,700 staff and has a trailing 12-month revenue of around 0.00.

Integra LifeSciences Holdings Corporation stock price (NASDAQ: IART)

Use our graph to track the performance of IART stocks over time.

Integra LifeSciences Holdings Corporation shares at a glance

• Key figures

Information last updated 2021-07-24.

Latest market close	$69.05
52-week range	$42.12 - $77.40
50-day moving average	$68.61
200-day moving average	$69.16
Wall St. target price	$77.55
PE ratio	34.3703
Dividend yield	N/A (0%)
Earnings per share (TTM)	$1.99

Buy Integra LifeSciences Holdings Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Integra LifeSciences Holdings Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Integra LifeSciences Holdings Corporation by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Integra LifeSciences Holdings Corporation price performance over time

Historical closes compared with the close of $69.05 from 2021-05-28

1 week (2021-07-15)	N/A
1 month (2021-06-25)	-1.41%
3 months (2021-04-26)	-9.62%
6 months (2021-01-22)	N/A

1 year (2020-07-22)	N/A
2 years (2019-07-22)	N/A
3 years (2018-07-22)	N/A
5 years (2016-07-22)	N/A

Is Integra LifeSciences Holdings Corporation under- or over-valued?

Valuing Integra LifeSciences Holdings Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Integra LifeSciences Holdings Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Integra LifeSciences Holdings Corporation's P/E ratio

Integra LifeSciences Holdings Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 34x. In other words, Integra LifeSciences Holdings Corporation shares trade at around 34x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Integra LifeSciences Holdings Corporation's PEG ratio

Integra LifeSciences Holdings Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.7817. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Integra LifeSciences Holdings Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Integra LifeSciences Holdings Corporation's EBITDA

Integra LifeSciences Holdings Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $347.2 million.

The EBITDA is a measure of a Integra LifeSciences Holdings Corporation's overall financial performance and is widely used to measure a its profitability.

Integra LifeSciences Holdings Corporation financials

Revenue TTM	$1.4 billion
Operating margin TTM	16.78%
Gross profit TTM	$885.6 million
Return on assets TTM	4.02%
Return on equity TTM	11.85%
Profit margin	12.35%
Book value	$18.10
Market capitalisation	$5.8 billion

TTM: trailing 12 months

Shorting Integra LifeSciences Holdings Corporation shares

There are currently 4.2 million Integra LifeSciences Holdings Corporation shares held short by investors – that's known as Integra LifeSciences Holdings Corporation's "short interest". This figure is 3.8% up from 4.0 million last month.

There are a few different ways that this level of interest in shorting Integra LifeSciences Holdings Corporation shares can be evaluated.

Integra LifeSciences Holdings Corporation's "short interest ratio" (SIR)

Integra LifeSciences Holdings Corporation's "short interest ratio" (SIR) is the quantity of Integra LifeSciences Holdings Corporation shares currently shorted divided by the average quantity of Integra LifeSciences Holdings Corporation shares traded daily (recently around 338421.50363783). Integra LifeSciences Holdings Corporation's SIR currently stands at 12.37. In other words for every 100,000 Integra LifeSciences Holdings Corporation shares traded daily on the market, roughly 12370 shares are currently held short.

However Integra LifeSciences Holdings Corporation's short interest can also be evaluated against the total number of Integra LifeSciences Holdings Corporation shares, or, against the total number of tradable Integra LifeSciences Holdings Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Integra LifeSciences Holdings Corporation's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Integra LifeSciences Holdings Corporation shares in existence, roughly 50 shares are currently held short) or 0.0575% of the tradable shares (for every 100,000 tradable Integra LifeSciences Holdings Corporation shares, roughly 58 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Integra LifeSciences Holdings Corporation.

Find out more about how you can short Integra LifeSciences Holdings Corporation stock.

Integra LifeSciences Holdings Corporation share dividends

We're not expecting Integra LifeSciences Holdings Corporation to pay a dividend over the next 12 months.

Have Integra LifeSciences Holdings Corporation's shares ever split?

Integra LifeSciences Holdings Corporation's shares were split on a 2:1 basis on 3 January 2017. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Integra LifeSciences Holdings Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Integra LifeSciences Holdings Corporation shares which in turn could have impacted Integra LifeSciences Holdings Corporation's share price.

Integra LifeSciences Holdings Corporation share price volatility

Over the last 12 months, Integra LifeSciences Holdings Corporation's shares have ranged in value from as little as $42.12 up to $77.4. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Integra LifeSciences Holdings Corporation's is 1.2312. This would suggest that Integra LifeSciences Holdings Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Integra LifeSciences Holdings Corporation overview

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. It operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, hydrocephalus management systems, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, bone and joint fixation implants in the upper and lower extremities, and bone grafts products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally.

Frequently asked questions

What percentage of Integra LifeSciences Holdings Corporation is owned by insiders or institutions?
Currently 14.065% of Integra LifeSciences Holdings Corporation shares are held by insiders and 90.05% by institutions. How many people work for Integra LifeSciences Holdings Corporation?
Latest data suggests 3,700 work at Integra LifeSciences Holdings Corporation. When does the fiscal year end for Integra LifeSciences Holdings Corporation?
Integra LifeSciences Holdings Corporation's fiscal year ends in December. Where is Integra LifeSciences Holdings Corporation based?
Integra LifeSciences Holdings Corporation's address is: 1100 Campus Road, Princeton, NJ, United States, 08540 What is Integra LifeSciences Holdings Corporation's ISIN number?
Integra LifeSciences Holdings Corporation's international securities identification number is: US4579852082 What is Integra LifeSciences Holdings Corporation's CUSIP number?
Integra LifeSciences Holdings Corporation's Committee on Uniform Securities Identification Procedures number is: 457985109